SMAD4 and cancer: The overall survival (OS) of patients was significantly associated with the following factors: CA19-9 level, cancer location, T stage, N stage, major vessel resection, resection margin status, tumor differentiation, presence of perineural invasion, presence of lymphovascular invasion, inactivation of the DPC4 gene, and adjuvant therapy.